Skip to content
November 17, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Surgery and Reconstruction
  • Bridging the Gap: The Breast Surgery Collaborative Community Proposes Streamlined FDA Patient Decision Checklist
  • Breast Cancer Surgery and Reconstruction

Bridging the Gap: The Breast Surgery Collaborative Community Proposes Streamlined FDA Patient Decision Checklist

Asep Darmawan November 17, 2026 8 minutes read
bridging-the-gap-the-breast-surgery-collaborative-community-proposes-streamlined-fda-patient-decision-checklist

ARLINGTON HEIGHTS, IL — The landscape of breast surgery informed consent is on the cusp of a significant transformation. The Breast Surgery Collaborative Community (BSCC), a multi-stakeholder coalition comprising patients, board-certified plastic surgeons, and industry representatives, has officially submitted a proposal to the U.S. Food and Drug Administration (FDA) to overhaul the current Breast Implant Patient Decision Checklist.

For years, the medical community has grappled with the balance between comprehensive regulatory disclosure and the practical limitations of the clinical consultation room. Now, the BSCC is inviting the public to weigh in on a revised version of the checklist, aiming to distill complex safety data into a more accessible, actionable, and meaningful educational tool.


The Genesis of the Checklist: A Chronology of Informed Consent

To understand the necessity of this proposal, one must look at the evolution of FDA oversight regarding breast implants.

The 2022 Implementation

In 2022, the FDA introduced a mandatory Patient Decision Checklist as part of its updated safety requirements for breast implants. The goal was noble: to ensure that patients—particularly those undergoing breast augmentation or reconstruction—were fully aware of the risks, including the potential for complications, reoperation, and the rare but serious association with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and Breast Implant Illness (BII) symptoms.

The Growing Pains

While the intent behind the 2022 checklist was to empower patients, the reality of its implementation quickly drew criticism. Clinicians reported that the document was excessively lengthy and dense with technical jargon. Surgeons noted that the time required to review the document often detracted from the quality of the interpersonal, shared decision-making process. Patients, meanwhile, expressed feeling overwhelmed rather than informed, describing a document that felt like a "legal shield" for manufacturers rather than an educational guide for their own health journeys.

The Consensus-Based Pivot

Recognizing these challenges, the BSCC—an organization formed to bridge the gap between regulatory bodies, patients, and surgeons—launched a multi-year, consensus-based effort. Over the last several years, this group, which includes advocates from organizations like the Breast Implant Safety Alliance and the Young Survival Coalition, worked to synthesize feedback from the front lines of clinical practice. The result is a revised document that prioritizes clarity, readability, and patient-centered design.


Supporting Data: Why "More" Isn’t Always "Better"

The drive toward a shorter, more concise checklist is supported by established principles of health literacy. Research consistently shows that when patients are presented with an overload of information, their ability to retain and understand critical safety details decreases.

The Burden of Cognitive Overload

In the context of plastic surgery, patients are often managing significant emotional and physical stress. A multi-page document filled with dense text and regulatory legalese can inadvertently cause "information fatigue." By streamlining the checklist, the BSCC aims to:

  • Improve Retention: Focusing on the most pertinent safety data allows patients to better grasp the risks and benefits.
  • Enhance Engagement: A shorter document serves as a conversation starter rather than a static form, encouraging patients to ask deeper, more relevant questions during their consultation.
  • Standardize Quality: A more usable tool is more likely to be utilized consistently across different practices, ensuring a baseline standard of care for every patient, regardless of their location.

Official Responses and Collaborative Perspectives

The strength of the BSCC’s proposal lies in the diversity of its membership. The group is not merely a medical organization; it is a collaborative community in the truest sense, integrating the voices of those who live with implants alongside those who design and implant them.

A Unified Front

The committee responsible for the revision includes high-ranking members of the American Society of Plastic Surgeons (ASPS) and The Aesthetic Society, alongside dedicated patient advocates. This ensures that the document does not sacrifice clinical accuracy for brevity.

"Our goal was never to remove information," said a representative from the BSCC during the announcement. "Our goal was to refine how that information is delivered. We want to ensure that when a patient signs that checklist, they are not just checking a box, but confirming that they have had a meaningful, high-quality conversation with their surgeon."

The Role of Industry

Even representatives from major manufacturers—including Mentor Worldwide LLC, Establishment Labs, and Sientra—have participated in the collaborative effort. Their inclusion provides a transparent view of device technology and safety profiles, ensuring that the checklist reflects the current state of medical device engineering while remaining grounded in the lived experience of patients.

Breast Surgery Collaborative Community Invites Public Comment on Updated FDA Patient Decision Checklist

Implications for the Future of Shared Decision-Making

The BSCC’s proposal has profound implications for the future of elective and reconstructive surgery. If adopted by the FDA, this shift could set a new precedent for how regulatory bodies interact with medical professionals and patients.

Strengthening the Surgeon-Patient Relationship

The "shared decision-making" model is a pillar of modern medicine. By removing the friction of an overly burdensome checklist, the BSCC hopes to give time back to the physician and patient. Instead of spending 20 minutes reviewing a dense document, that time can be reallocated to discussing a patient’s specific goals, their anatomy, and their personal risk factors.

Setting a Regulatory Standard

The BSCC operates within the framework of FDA Collaborative Communities. This model is designed to solve systemic problems that are too complex for any one stakeholder to tackle alone. If this initiative succeeds, it could serve as a template for other medical devices or surgical procedures that require complex informed consent processes.


How to Participate: A Call for Public Input

The BSCC is firm in its belief that the final document must reflect the needs of the people it is designed to protect. Consequently, the revised checklist is now available for public review.

Submission Guidelines

The FDA has opened a public docket to collect feedback on the proposal. Interested parties—patients, surgeons, nurses, and researchers—are encouraged to review the document and provide their thoughts.

  • Submission Deadline: December 1, 2026.
  • Link for Comments: https://www.regulations.gov/comment/FDA-2019-D-4467-1386
  • Tracking Number: To ensure your feedback is categorized correctly under the BSCC proposal, please include the following tracking number in your submission: mt7-xgl2-2crx.

About the Breast Surgery Collaborative Community (BSCC)

The BSCC is a vital forum for communication between the FDA, medical professional organizations, and the public. By fostering a space where private- and public-sector members can align on common objectives, the community addresses the most pressing challenges in breast surgery.

Members represent a broad coalition of expertise, including:

  • The American Society of Plastic Surgeons (ASPS)
  • The Aesthetic Society
  • The Plastic Surgery Foundation
  • The Aesthetic Foundation
  • Breast Implant Safety Alliance (BISA)
  • Young Survival Coalition
  • FORCE: Facing Our Risk of Cancer Empowered

By prioritizing patient advocacy alongside surgical excellence, the BSCC continues to push the boundaries of what is possible in safety and education.


Looking Ahead: The Path to Finalization

As the comment period progresses, the BSCC will review the feedback gathered from the public. This iterative process is the final step in a long journey toward a more effective informed consent experience.

For the patient, this means the possibility of a clearer path forward. For the surgeon, it means a more effective clinical tool. And for the FDA, it represents the success of the collaborative community model—a testament to what happens when all stakeholders sit at the same table to solve problems for the public good.

As we look toward the December 2026 deadline, the message from the BSCC is clear: the conversation about breast surgery safety is evolving, and everyone has a role to play in defining its future.


Members of the Breast Surgery Collaborative Community (BSCC)

  • William P. Adams Jr., MD (The Aesthetic Society/The Aesthetic Foundation)
  • Scot B. Glasberg, MD (ASPS/PSF)
  • George Chatson, MD (ASPS/PSF)
  • Jennifer Cook (Patient and Advocate, BISA)
  • Lynn Damitz, MD (ASPS/PSF)
  • Melinda Haws, MD (The Aesthetic Society/The Aesthetic Foundation)
  • Amanda Hynum (Patient Advocate, Oregon Health and Science University)
  • Cynthia Johnson, RN (Patient Advocate)
  • Debra Johnson, MD (At Large PS Representative)
  • Meristacia Kingston, MD (Patient Advocate, Pediatric Hospitalist Fellow)
  • Patricia McGuire, MD (The Aesthetic Society/The Aesthetic Foundation)
  • Kimberly Platt, MSN, RN, CAPA (Patient Advocate, Registered Nurse)
  • Sheryl Robinson-Collins (Mentor Worldwide LLC)*
  • Margie Rose, MPH (Establishment Labs/Motiva)*
  • Sara Saul, PhD (Tiger Aesthetics/Sientra)*
  • Briana Theroux (At Large Patient/Author/Nutrition Psychology)
  • Jamil Ahmad, MD (The Aesthetic Society President – Ex-Officio)*
  • C. Bob Basu, MD, MBA, MPH, FACS (ASPS President – Ex-Officio)*

*Non-voting members

About the Author

Asep Darmawan

Author

View All Posts

Post navigation

Previous: Bridging the Accessibility Gap: Marrow Therapeutics Emerges with a "Trojan Horse" for Sickle Cell Disease

Related Stories

the-art-of-being-unnoticed-new-research-reveals-how-nasal-aesthetics-shape-facial-perception
  • Breast Cancer Surgery and Reconstruction

The Art of Being Unnoticed: New Research Reveals How Nasal Aesthetics Shape Facial Perception

Rifan Muazin November 17, 2026
the-future-of-breast-reconstruction-autologous-fat-transfer-offers-a-natural-alternative-post-mastectomy
  • Breast Cancer Surgery and Reconstruction

The Future of Breast Reconstruction: Autologous Fat Transfer Offers a Natural Alternative Post-Mastectomy

Evan Lee Salim November 16, 2026
advancing-the-future-of-reconstructive-science-dr-sara-r-dickie-named-president-of-the-plastic-surgery-foundation
  • Breast Cancer Surgery and Reconstruction

Advancing the Future of Reconstructive Science: Dr. Sara R. Dickie Named President of The Plastic Surgery Foundation

Azzam Bilal Chamdy November 16, 2026

Recent Posts

  • Bridging the Gap: The Breast Surgery Collaborative Community Proposes Streamlined FDA Patient Decision Checklist
  • Bridging the Accessibility Gap: Marrow Therapeutics Emerges with a "Trojan Horse" for Sickle Cell Disease
  • FDA Grants Accelerated Approval to Inovio’s Voceryq Amid Scrutiny of Delivery Device Ergonomics
  • A New Horizon in Breast Cancer Prevention: Targeting Obesity and Metabolism with a Novel Drug Combination
  • Forging Impactful Alliances: How Strategic Corporate-Nonprofit Partnerships Drive Shared Value and Lasting Change

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

bridging-the-gap-the-breast-surgery-collaborative-community-proposes-streamlined-fda-patient-decision-checklist
  • Breast Cancer Surgery and Reconstruction

Bridging the Gap: The Breast Surgery Collaborative Community Proposes Streamlined FDA Patient Decision Checklist

Asep Darmawan November 17, 2026
bridging-the-accessibility-gap-marrow-therapeutics-emerges-with-a-trojan-horse-for-sickle-cell-disease
  • Chemotherapy and Targeted Therapy

Bridging the Accessibility Gap: Marrow Therapeutics Emerges with a "Trojan Horse" for Sickle Cell Disease

Nana November 17, 2026
fda-grants-accelerated-approval-to-inovios-voceryq-amid-scrutiny-of-delivery-device-ergonomics
  • Chemotherapy and Targeted Therapy

FDA Grants Accelerated Approval to Inovio’s Voceryq Amid Scrutiny of Delivery Device Ergonomics

Pevita Pearce November 17, 2026
a-new-horizon-in-breast-cancer-prevention-targeting-obesity-and-metabolism-with-a-novel-drug-combination
  • Medical Research and Clinical Trials

A New Horizon in Breast Cancer Prevention: Targeting Obesity and Metabolism with a Novel Drug Combination

Jia Lissa November 17, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.